Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology Read more
Otsuka and Lundbeck Announce FDA Approval of Supplemental New Drug Application (sNDA) for REXULTI (brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer’s Disease Read more
FDA accepts application for Roche’s Vabysmo for the treatment of retinal vein occlusion (RVO) Read more
AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL TARGETS IN CROHN’S DISEASE Read more
Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next Generation Sequencing-Based Testing for Cancer Patients in International Markets Read more
CureVac Announces Dosing of First Participant in Combined Phase 1/2 Study of Multivalent, Modified Influenza Vaccine Candidates Developed in Collaboration with GSK Read more
ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s Disease Read more
Roche launches Institute of Human Biology to accelerate breakthroughs in R&D by unlocking the potential of human model systems Read more
Amphista Therapeutics Achieves First Discovery Milestone in Collaboration with Bristol Myers Squibb Read more
ARTHEx Biotech Announces Closing of €42 M Series B Financing to Advance ATX-01, its Novel Treatment for Myotonic Dystrophy Type 1 (DM1) Read more